Tag | Content |
---|
EnhancerAtlas ID | HS088-04332 |
Organism | Homo sapiens |
Tissue/cell | HeLa-S3 |
Coordinate | chr1:173374210-173376400 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
IRF1 | MA0050.2 | chr1:173376029-173376050 | GGGGTGAAAGTGAAAGTGAAC | - | 7.39 | IRF2 | MA0051.1 | chr1:173376033-173376051 | TGAAAGTGAAAGTGAACA | + | 6.35 | NEUROD2 | MA0668.1 | chr1:173374345-173374355 | GCCATATGGT | + | 6.02 | Nkx3-2 | MA0122.3 | chr1:173374514-173374527 | TCAACCACTTAAA | + | 6.24 | PRDM1 | MA0508.2 | chr1:173376032-173376042 | GTGAAAGTGA | - | 6.02 | PRDM1 | MA0508.2 | chr1:173376038-173376048 | GTGAAAGTGA | - | 6.02 | ZNF263 | MA0528.1 | chr1:173376083-173376104 | TGAGCAGGGCGAGGAGGGGAA | + | 6.44 |
|
| Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
SE_11670 | chr1:173375124-173388930 | CD20 | SE_59309 | chr1:173375281-173399883 | Ly3 | SE_61594 | chr1:173375372-173401064 | Toledo |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 2 | ID | Chromosome | Start | End |
GH01I173405 | chr1 | 173375058 | 173375430 | GH01I173406 | chr1 | 173375740 | 173377277 |
|
Enhancer Sequence | TCCCCTATTA AATGTAAGTT TCCTGTGGGC AGAGATTTCT GTCTGTTTTG CTCACTGATG 60 CATCCCAAGT ACCTAAACAG CCAACGGCAA GTCCCAAGGT AAAGGGCTAG ACTGCAAATA 120 TGTTCGACTT TGTGGGCCAT ATGGTTTCCA TTGCAACTAC TCAACTCTGC CTTCATAAGA 180 CAAAAGCAGC CACACTAACA CACAAAATGG GTGTAGCTGG GGTCCAGTAA AATTTTATTT 240 ACAGGCACTG CAACTCAAAT GTAATATAAT CTTCACACAT CACAATATAT TTGGCTTTTG 300 TTTTTCAACC ACTTAAAAGT ATAAAAACTA TTCTTAGTTC ACAGGCCACA TAAACAGGCA 360 GCAGGCTGGA ATTGGCCCAC AGGTCACAGT TTACCAATCC CTGAGCCAGA ATCTATTAAG 420 GGCTCACATG GAAACCACTG TGCCAAGATA TTTGAGGGCA CTTGAAAGTG GGATGTTACT 480 TTAAGTATAT GAAACATTTC TTATACAATC AAGTATACAC ACATTATTAA TGTGTTTGCC 540 AGGTACCTTT CCATAGTACC AAGGTAAATT TAGGTTTATT CACTGTCTGA ATCATGTACA 600 ACTCATTTAA ATTAAATAAG ATTGGCACAA TGAAGTTGTC AAGTTTTCAA AGATTACATA 660 AAAAGAGTAG ATGGTAAACA ATTCTGGCCC TAAACATCTC ATGCATCTCA CATTGTACCT 720 CATTGATAAA TCCAAATTTC CAGCATGAGC ATTGGATTTG ATTTTATTAT TGTTTAAAAA 780 GCAATTGACA GAACTAGTAA CTAAACCAGT TATGATGCTG TAGGCATTTT CAACTGTGAC 840 TCATACTGCG AAATATGGAG TTAGCTCATC TCAACAGGAC AGAAAAGGCT GCATGGCACG 900 TGGGTGTGTG TTATTGGATC TAGAGTTTGA TCTCGACCCA CTTCTCACCT GTGGGCCCTG 960 TGCATTTGAG TTATCTGGTA AGGAGGGTGG GCCCAGATCA GTTTTCACAC TGGCAAGTTA 1020 GTTCAAGGCT ATATTCTTGT AGACACACCC TGCTTTCCCA AAACTGAGGT AGACATTGTG 1080 CAATACCATA CAAACACACT CAAAGGAAGC AGGGCTTTGG CATATAGTAG GCACTCAATA 1140 AATATTTGAA TCAACAAATA AATATATGGA TAGCTCTGAA CTACTAGGGG GAAAAAAAGC 1200 ACTCATTTGA GTAAACAGGT CATCATTAAT TATTATTTAC TGTACTCTAT TCTTGTCTGC 1260 CATAGGAAAA ACAAGAGCTA TATGCCCCAG TGCTTGACCA CTTATTTATT TACTTATTTC 1320 ACAAAAATTA TTAAATACCT ACTATGTTCC AGGAACTCTA CAGGGAATTT GGCCTACATA 1380 GCTAACGAAG ACATTACAGG GTTGCATTAT AACTTCCATG AGTCCTAGGC ACTTTTGCCT 1440 TCATGGACCC CTTCTTCCAT TAAAAAAATT AAAATTTTTA TTTTACATTG TCTTAAAGAT 1500 AAATATAATT CAGGCCGGAT TCATTGCTAT GTTCTTAATT ATTATACTCA CTATTTCTTC 1560 AGAATTTAAA AGCAATTAAT ATGAAAACAT TGTCGTGGAC CCTAAAATTA CCCTGGGCCC 1620 TGGGCTCTGT GTCTGTTGTG CCCAGTGGGG CGATTGCCCT GCGACAGTCT CTGTCTTCCT 1680 GCCTCCTGTC CTGAATGAAT CGGTCCAAAT GTTACTCAAA GGAGCTGATC AAAGTAGCTG 1740 GGACCTGGAG AGAATTCCCA GGTGTGGGAA TCCTGAGAGG TAATTACGGA GAGCTTCCGA 1800 ATGGAGAGCC TGTGGCCGTG GGGTGAAAGT GAAAGTGAAC AGTGACAGCG GCCTGTTGGG 1860 TGGTACTGGG TTCTGAGCAG GGCGAGGAGG GGAATCTAGT TGGGGGGATG GGGAGACAGT 1920 AGCAATGGCA AGGCAGGATA TTACAGCAGC AGCAGGATGA GAAGGGTGAC TGCCTCACTC 1980 GGTGCAGACT GCTGGCACCT GAGTGGAGTA AGGCTGATGG CTGTGCAGGG AGCAAAGGCA 2040 GTGGCCACTG GGGAGGCAGG TGGTGCGGGA GGGGAGAAAA GCAGACCAAA CAGCCTGGCT 2100 GGGGTGTTGG GGCCCAAGAA GGATGAGGAG GATATTAGCA CAGTCCGTGT GGAGTGTCAG 2160 AACCTGAGGG TAGATCAAGG TAACCAGCTT 2190
|